The COVALAC Study: The Impact of COVID-19 Vaccination During Lactation on SARS-CoV-2-Specific Antibodies in Human Milk

Abstract

Background:

The COVID-19-pandemic prompted global vaccination campaigns, raising important questions about vaccine-induced immune responses in lactating women and the transfer of SARS-CoV-2-specific antibodies through human milk. This study investigated the presence of SARS-CoV-2-specific IgA and IgG antibodies in breastmilk for up to 6 months following COVID-19 vaccination and booster doses with either mRNA or adenoviral vector (AVV) vaccines.

Method:

The COVALAC-study was a prospective cohort study conducted in Belgium. Women were recruited between February and March 2021, followed for 180 days post-vaccination and 28 days post-booster. Breastmilk samples were collected at multiple timepoints and analyzed for IgA and IgG antibodies. Participants received either mRNA (BNT162b2, mRNA-127) or AVV (ChAdOx1 nCoV-19) vaccines. Antibody concentrations were measured using an in-house immunoassay, and analyses compared responses between vaccine types.

Results:

Of the 115 participants, 40% received BNT162b2, 4.3% mRNA-1273, and 55.7% ChAdOx1-S as their primary vaccination. Of these, 31 participants received an mRNA booster (11 homologous, 20 heterologous boosters). IgA and IgG antibody levels were monitored pre- and post-vaccination, showing a stronger antibody response after mRNA vaccination compared to AVV, after roughly 14 days (IgA receptor binding domain [RBD] 1.13 BAU/mil; 0.61–1.67; IgG RBD 2.56 BAU/mil; 0.76–4.71, up to 1 month, for most antibodies. Both homologous and heterologous boosters further increased antibody titers (IgA RBD 0,85 BAU/ml; 1.09–1.72).

Conclusion:

COVID-19 vaccination during lactating induces SARS-CoV-2 specific IgA and IgG antibodies in human milk. Antibody levels were higher following mRNA vaccination compared to AVV vaccination, with booster doses enhancing these levels further.

Keywords

antibody breastfeeding COVID-19 immunology lactation

Get full access to this article

View all access options for this article.

References

Atyeo

Shook

L. L.

Nziza

Deriso

E. A.

Muir

Baez

A. M.

Lima

R. S.

Demidkin

Brigida

De Guzman

R. M.

Burns

M. D.

Balazs

A. B.

Fasano

Yonker

L. M.

Gray

K. J.

Alter

Edlow

A. G.

(2023). COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women. American Journal of Obstetrics and Gynecology, 228(1), 68.e1–68.e12. https://doi.org/10.1016/j.ajog.2022.07.014

BCFI. (2021). COVID-19 Vaccin van AstraZeneca: In België Nu Enkel Nog Vanaf de Leeftijd van 41 Jaar, Maar Geen Leeftijdsbeperking Voor Wie Reeds 1ste Dosis Kreeg [AstraZeneca’s COVID-19 Vaccine: in Belgium now only available from the age of 41, but no age limit for those who already received the first dose]. https://www.bcfi.be/nl/covid-19-vaccin-van-astrazeneca-in-belgie-nu-enkel-nog-vanaf-de-leeftijd-van-41-jaar-maar-geen-leeftijdsbeperking-voor-wie-reeds-1ste-dosis-kreeg/

Bürkner

P.-C.

(2017). Brms: An R package for Bayesian multilevel models using Stan. Journal of Statistical Software, 80(1), 1–28. https://doi.org/doi:10.18637/jss.v080.i01

Collier

A. Y.

McMahan

Tostanoski

L. H.

Aguayo

Ansel

Chandrashekar

Patel

Apraku Bondzie

Sellers

Barrett

Sanborn

Wan

Chang

Anioke

Nkolola

Bradshaw

Jacob-Dolan

Feldman

, . . . Barouch

D. H.

(2021). Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. Journal of the American Medical Association, 325(23), 2370–2380. https://doi.org/10.1001/jama.2021.7563

European Medicines Agency. (2021). AstraZeneca’s COVID-19 vaccine: Benefits and risks in context (pp. 2–6). https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-benefits-and-risks-context

Golan

Ilala

Gay

Hunagund

Lin

C. Y.

Cassidy

A. G.

Jigmeddagva

Matsui

Ozarslan

Asiodu

I. V.

Ahituv

Flaherman

V. J.

Gaw

S. L.

Prahl

(2023). Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection. IScience, 26(10), Article 107767. https://doi.org/10.1016/j.isci.2023.107767

Golan

Prahl

Cassidy

A. G.

Gay

A. H. B.

Jigmeddagva

Lin

C. Y.

Gonzalez

V. J.

Basilio

Warrier

Buarpung

Asiodu

I. V.

Ahituv

Flaherman

V. J.

Gaw

S. L.

(2021). COVID-19 mRNA vaccination in lactation: Assessment of adverse events and Vaccine related Antibodies in Mother-Infants Dyads. MedRxiv: The Preprint Server for Health Sciences. https://doi.org/10.1101/2021.03.09.21253241

Guan

W.-j.

Z.-y.

Liang

W.-h.

C.-q.

J.-x.

Liu

Shan

Lei

C.-l.

Hui

D. S. C.

L.-j.

Zeng

Yuen

K.-Y.

Chen

R.-c.

Tang

C.-l.

Wang

Chen

P.-y.

Xiang

, . . . Zhong

N.-s.

(2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/nejmoa2002032

Hagenbeck

Zöllkau

Helbig

Fehm

Schaal

N. K.

(2023). COVID-19 vaccination during pregnancy and lactation: Attitudes and uptakes before and after official recommendations in Germany. Vaccines, 11(3), Article 627. https://doi.org/10.3390/vaccines11030627

10.

Hare

Womersley

. (2021). Why were breastfeeding Women in the UK denied the Covid-19 vaccine? British Medical Journal, 372, 5–6. https://www.doi.org/10.1136/bmj.n4

11.

Heinz

F. X.

Stiasny

. (2021). Distinguishing features of current COVID-19 vaccines: Knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines, 6, 1–13. https://doi.org/10.1038/s41541-021-00369-6

12.

Hoddinott

(2008). Breast feeding. BMJ, 336, 881.

13.

Lechosa-Muñiz

Paz-Zulueta

Mendez-Legaza

J. M.

Irure-Ventura

Cuesta González

Calvo Montes

López-Hoyos

Llorca

Jesús Cabero-Pérez

(2021). Induction of SARS-CoV-2-Specific IgG and IgA in serum and milk with different SARS-CoV-2 vaccines in breastfeeding women: A cross-sectional study in Northern Spain. International Journal of Environmental Research and Public Health, 18(16), 1–12. https://doi.org/10.3390/ijerph18168831

14.

Merewood

Bode

Davanzo

Perez-Escamilla

. (2021). Breastfeed or be vaccinated—an unreasonable default recommendation. Lancet, 397(578). https://www.doi.org/10.1016/S0140-6736(21)00197-5

15.

Muyldermans

De Weerdt

De Brabandere

Maertens

Tommelein

(2022). The effects of COVID-19 vaccination on lactating women: A systematic review of the literature. Frontiers in Immunology, 13, Article 852928. https://doi.org/10.3389/fimmu.2022.852928

16.

Novillo

Martínez-Varea

(2023). COVID-19 vaccines during pregnancy and breastfeeding: A systematic review. Journal of Personalized Medicine, 13(1), Article 40. https://doi.org/10.3390/jpm13010040

17.

Pace

R. M.

Williams

J. E.

Järvinen

K. M.

Belfort

M. B.

Pace

C. D. W.

Lackey

K. A.

Gogel

A. C.

Nguyen-Contant

Kanagaiah

Fitzgerald

Ferri

Young

Rosen-Carole

Diaz

Meehan

C. L.

Caffé

Sangster

M. Y.

Topham

McGuire

M. A.

, . . . McGuire

M. K.

(2021). Characterization of Sars-Cov-2 RNA, antibodies, and neutralizing capacity in milk produced by women with Covid-19. MBio, 12(1), 1–11. https://doi.org/10.1128/mBio.03192-20

18.

Pavord

Makris

(2022). Second-dose VITT: Rare but real. Blood, 139(17), 2580–2581. https://doi.org/10.1182/blood.2022016118

19.

Perez

S. E.

Luna Centeno

L. D.

Cheng

W. A.

Marentes Ruiz

C. J.

Lee

Congrave-Wilson

Powell

R. L.

Stellwagen

Pannaraj

P. S.

(2022). Human milk SARS-CoV-2 antibodies up to 6 months after vaccination. Pediatrics, 149(2), Article e2021054260. https://doi.org/10.1542/peds.2021-054260

20.

R Core Team. (2023). R: A language and environment for statistical computing: R foundation for statistical computing. www.R-project.org

21.

Ramasamy

M. N.

Minassian

A. M.

Ewer

K. J.

Flaxman

A. L.

Folegatti

P. M.

Owens

D. R.

Voysey

Aley

P. K.

Angus

Babbage

Belij-Rammerstorfer

Berry

Bibi

Bittaye

Cathie

Chappell

Charlton

Cicconi

Clutterbuck

E. A.

, . . . the Oxford COVID Vaccine Trial Group. (2020). Safety and immunogenicity of ChAdOx1 NCoV-19 vaccine administrered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396(10267), 1979–1993. https://doi.org/10.1016/S0140-6736(20)32466-1

22.

Ramlawi

Muldoon

K. A.

Dunn

S. I.

Murphy

M. S. Q.

Dingwall-Harvey

A. L. J.

Rennicks White

Fakhraei

Wen

S. W.

Walker

M. C.

Fell

D. B.

Bogler

El-Chaâr

(2022). Worries, beliefs and factors influencing perinatal COVID-19 vaccination: A cross-sectional survey of preconception, pregnant and lactating individuals. BMC Public Health, 22(1), 1–13. https://doi.org/10.1186/s12889-022-14617-4

23.

Robinson

Jones

Lesser

Daly

(2021). International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine, 39(15), 2024–2034. https://doi.org/10.1016/j.vaccine.2021.02.005

24.

Schwartz

Nir

Toussia-Cohen

(2021). Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. American Journal of Obstetrics & Gynecology, 225(5), 577–579. https://doi.org/10.1016/j.ajog.2021.07.016

25.

Selma-Royo

Bauerl

Mena-Tudela

Aguilar-Camprubi

Jose Perez-Cano

Parra-Llorca

Lerin

Martinez-Costa

Carmen Collado

(2021). Anti-Sars-Cov-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous Sars-Cov-2 exposure a longitudinal study. Genome Medicine, 14(42), 1–11. https://doi.org/10.1101/2021.05.20.21257512

26.

United Nations Children’s Fund. (2019). Breastfeeding and family-friendly policies an evidence brief breastfeeding and family-friendly policies; An evidence brief. https://www.unicef.org/sites/default/files/2019-07/UNICEF-Breastfeeding-Family-Friendly%20Policies-2019.pdf

27.

Valverde-Merino

M. I.

Gomez-Guzman

Piquer-Martinez

Lopez

M. D. C.

Zarzuelo

M. J.

(2024). The importance of COVID-19 vaccination during lactation. Infectious Diseases Now, 54(1), Article 104831. https://doi.org/10.1016/j.idnow.2023.104831

28.

Wambach

Spencer

(2020). Breastfeeding and human lactation ( Wambach

Spencer

, Eds.; 6th ed.). Sheridan Books.

29.

World Health Organization. (2020). Who-Director-General-s-Opening-Remarks-at-the-Media-Briefing-on-Covid-19—11-March-2020. https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

30.

World Health Organization. (n.d.). Exclusive breastfeeding for six months best for babies everywhere. https://www.who.int/news/item/15-01-2011-exclusive-breastfeeding-for-six-months-best-for-babies-everywhere

The COVALAC Study: The Impact of COVID-19 Vaccination During Lactation on SARS-CoV-2-Specific Antibodies in Human Milk—A Prospective Cohort Study

Abstract

Background:

Method:

Results:

Conclusion:

Keywords

Get full access to this article

References